Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
07/2011
07/14/2011WO2011031111A3 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient
07/14/2011WO2011019173A3 Compound containing 5-membered heterocycles, organic light-emitting device using same, and terminal comprising the latter
07/14/2011US20110172442 Amino acid derivative
07/14/2011US20110172441 Method for synthesis of anthracene derivative
07/14/2011US20110172335 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions
07/14/2011US20110172283 Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators
07/14/2011US20110172244 Compounds and compositions as modulators of gpr119 activity
07/14/2011US20110171678 Modified carbocyanine dyes and their conjugates
07/14/2011US20110170209 Oxime ester photoinitiators
07/14/2011CA2786327A1 Process for making a metabotropic glutamate receptor positive allosteric modulator - 874
07/13/2011EP2343290A1 Diamine derivatives as factor X inhibitors
07/13/2011EP2343285A2 Peptoid compounds
07/13/2011EP2343277A2 Novel compound and organic electronic device using same
07/13/2011EP2342237A1 Photoinitiator mixtures
07/13/2011EP2342202A1 Azaindole derivative
07/13/2011EP2342179A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
07/13/2011EP2342175A1 Nitric oxide releasing amino acid ester compound, composition and method of use
07/13/2011EP2342173A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
07/13/2011EP2137147B1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
07/13/2011EP1710234B1 Malononitrile compound and use thereof
07/13/2011EP1539717B1 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
07/13/2011EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient
07/13/2011EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents
07/13/2011CN102124008A Novel derivatives of pyrroloindole inhibitors of Hsp90, compositions containing same, and use thereof
07/12/2011US7977373 Prodrugs of ion channel modulating compounds and uses thereof
07/12/2011US7977331 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
07/12/2011US7977057 Detection of immobilized nucleic acid
07/12/2011CA2544305C Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins
07/12/2011CA2445341C Anthranilamides, process for their preparation, their use as antiarrhythmics, and pharmaceutical preparations thereof
07/07/2011WO2011082353A1 Separation and purification of monatin
07/07/2011WO2011082147A1 Chloro-substituted polyetherimides having improved relative thermal index
07/07/2011WO2011081061A1 Organic electroluminescent element
07/07/2011WO2011080718A1 Inhibitors of diacylglycerol acyl transferase
07/07/2011US20110166349 Gold catalyzed hydroamination of alkynes and allenes
07/07/2011US20110166170 Synthesis of avrainvillamide, stephacidin b, and analogues thereof
07/07/2011US20110166155 Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators
07/07/2011US20110166136 Calcium Ion Channel Modulators & Uses Thereof
07/06/2011EP2341045A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor
07/06/2011EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
07/06/2011EP2005500B1 Organic electronic devices using phthalimide compounds
07/06/2011EP1833789B1 Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid
07/06/2011CN102119151A Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof
07/06/2011CN102115478A Furo-indole compounds and preparation method and application thereof
07/06/2011CN102115457A Preparation method of N-ethylcarbazole
07/06/2011CN102115456A Cyanine compound, composition containing same and application in cell detection thereof
07/06/2011CN102115455A Method for preparing psilocine key intermediate
07/06/2011CN102114430A Catalyst and preparation method thereof as well as method for preparing N-alkylpyrrole derivatives
07/06/2011CN101200634B Soluble branch substituted anthracene molecule blue material as well as preparation method and uses thereof
07/06/2011CN101006048B Process for the synthesis c-2, c-3 substituted n-alkylated indoles useful as CPLA2 inhibitors
07/05/2011US7973173 Process for the synthesis of an ACE inhibitor
07/05/2011US7973172 Organic compound, semiconductor film electrode employing the organic compound, photoelectric conversion element employing the organic compound, and photoelectrochemical solar cell employing the organic compound
07/05/2011US7973070 Monatin hydrate crystals
07/05/2011US7973069 Methods for treating hepatitis C
07/05/2011US7973057 Thalidomide analogs
07/05/2011US7973042 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
07/05/2011US7973037 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
07/05/2011CA2564563C Indolyl derivatives as liver-x-receptor modulators
07/05/2011CA2531484C Novel bioisosteres of actinonin
07/05/2011CA2488630C Immunoadhesin comprising a glycoprotein vi domain
06/2011
06/30/2011WO2011079091A1 (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses
06/30/2011WO2011078163A1 Asymmetrical polyazo dye, manufacturing method for same, colouring agent and colouring method
06/30/2011WO2011076212A2 Processes for the manufacture of a pharmaceutically active agent
06/30/2011WO2011076086A1 Intermediate compounds of tamiflu, methods of preparation and uses thereof
06/30/2011US20110160433 Benzylic compound
06/30/2011US20110160269 Pyrrolin-2-ylamino Compounds For Combating Animal Pests
06/30/2011US20110160228 Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization
06/30/2011US20110160225 Compositions and methods of use for treating or preventing lipid related disorders
06/30/2011US20110160207 Heterocyclic amide compounds useful as kinase inhibitors
06/30/2011US20110160197 Substituted Indoles and a Method for the Production and Use Thereof
06/30/2011US20110158947 Sulfonylurea receptor and means for treating ischaemia
06/30/2011US20110155241 Dye for dye-sensitized solar cell, semiconductor electrode, and dye-sensitized solar cell
06/30/2011CA2785440A1 Processes for the manufacture of a pharmaceutically active agent
06/30/2011CA2783616A1 (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses
06/29/2011EP2338880A2 Polycarbonate with improved thermal and mechanical characteristics and reduced thermal expansion coefficients
06/29/2011EP2338879A1 New phenylhydrazone derivatives and their use as pharmaceuticals
06/29/2011EP2337785A1 N-phenyl carbazole-based host material for light-emitting diodes
06/29/2011EP2039354B1 Compounds blocking the nmda receptor channel and pharmaceutical agent using the same
06/29/2011EP1907394B1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
06/29/2011EP1767536B1 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
06/29/2011EP1730142B1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
06/29/2011EP0923932B1 Composition containing antitumor agent
06/29/2011CN102112497A Photoinitiator mixtures
06/29/2011CN102112468A New compounds
06/29/2011CN102112442A Process for preparation of macrocycle
06/29/2011CN102112441A Use of indole derivatives as NURR-1 activators for treating parkinson's disease
06/29/2011CN102112438A Oxime ester photoinitiators
06/29/2011CN101213173B Process for production of optically active aminopentane derivative, intermediate and process for producing the intermediate
06/28/2011US7968732 Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole
06/28/2011US7968731 Process for the purification of Ropinirole hydrochloride
06/28/2011US7968730 Synthesis of amines and intermediates for the synthesis thereof
06/28/2011US7968721 Coupling a N-phenyl-1-bromo-2-substituted propamide with a substituted hydroxy-, amino-, phosphino-, or seleno- benzene compound; crystallization and filtration; industrial scale, high purity; non-steroidal agonists
06/28/2011US7968601 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents
06/28/2011US7968589 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
06/28/2011US7968587 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
06/28/2011US7968585 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/28/2011US7968578 Indole amide derivatives as EP4 receptor antagonists
06/23/2011WO2011075634A1 Bicyclic derivatives useful as inhibitors of dpp-1
06/23/2011WO2011073173A1 Improved method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof
06/23/2011WO2011072704A1 Process for the preparation of ropinirole and salts thereof
06/23/2011WO2011072445A1 Preparation method of original dye of vat brown r
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 458